美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
25000-002-03	25000-002	HUMAN PRESCRIPTION DRUG	Benzonatate 100 mg	Benzonatate 100 mg	CAPSULE, LIQUID FILLED	ORAL	20260410	N/A	ANDA	ANDA220298	MARKSANS PHARMA LIMITED	BENZONATATE	100 mg/1	30 CAPSULE, LIQUID FILLED in 1 BOTTLE (25000-002-03)
25000-002-08	25000-002	HUMAN PRESCRIPTION DRUG	Benzonatate 100 mg	Benzonatate 100 mg	CAPSULE, LIQUID FILLED	ORAL	20260410	N/A	ANDA	ANDA220298	MARKSANS PHARMA LIMITED	BENZONATATE	100 mg/1	100 CAPSULE, LIQUID FILLED in 1 BOTTLE (25000-002-08)
25000-002-12	25000-002	HUMAN PRESCRIPTION DRUG	Benzonatate 100 mg	Benzonatate 100 mg	CAPSULE, LIQUID FILLED	ORAL	20260410	N/A	ANDA	ANDA220298	MARKSANS PHARMA LIMITED	BENZONATATE	100 mg/1	500 CAPSULE, LIQUID FILLED in 1 BOTTLE (25000-002-12)
25000-003-03	25000-003	HUMAN PRESCRIPTION DRUG	Benzonatate 200 mg	Benzonatate 200 mg	CAPSULE, LIQUID FILLED	ORAL	20260410	N/A	ANDA	ANDA220298	MARKSANS PHARMA LIMITED	BENZONATATE	200 mg/1	30 CAPSULE, LIQUID FILLED in 1 BOTTLE (25000-003-03)
25000-003-08	25000-003	HUMAN PRESCRIPTION DRUG	Benzonatate 200 mg	Benzonatate 200 mg	CAPSULE, LIQUID FILLED	ORAL	20260410	N/A	ANDA	ANDA220298	MARKSANS PHARMA LIMITED	BENZONATATE	200 mg/1	100 CAPSULE, LIQUID FILLED in 1 BOTTLE (25000-003-08)
25000-003-12	25000-003	HUMAN PRESCRIPTION DRUG	Benzonatate 200 mg	Benzonatate 200 mg	CAPSULE, LIQUID FILLED	ORAL	20260410	N/A	ANDA	ANDA220298	MARKSANS PHARMA LIMITED	BENZONATATE	200 mg/1	500 CAPSULE, LIQUID FILLED in 1 BOTTLE (25000-003-12)